340 related articles for article (PubMed ID: 30903445)
1. PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion.
Tamura R; Ohara K; Morimoto Y; Kosugi K; Oishi Y; Sato M; Yoshida K; Toda M
Endocr Pathol; 2019 Jun; 30(2):81-89. PubMed ID: 30903445
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors.
Sato M; Tamura R; Tamura H; Mase T; Kosugi K; Morimoto Y; Yoshida K; Toda M
J Clin Med; 2019 May; 8(5):. PubMed ID: 31100921
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
Kara M; Tokat F; Pamir MN; Danyeli AE
Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
[TBL] [Abstract][Full Text] [Related]
4. Ectopic Pituitary Neuroendocrine Tumors/Adenomas Around the Sella Turcica.
Demir MK; Ertem Ö; Kılıç D; Akıncı O; Ecertaştan Ö; Konya D; Kılıç T
Balkan Med J; 2024 May; 41(3):167-173. PubMed ID: 38454561
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
[TBL] [Abstract][Full Text] [Related]
6. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
Sarkar S; Chacko AG; Chacko G
J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
9. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
[TBL] [Abstract][Full Text] [Related]
10. Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.
Raverot G; Dantony E; Beauvy J; Vasiljevic A; Mikolasek S; Borson-Chazot F; Jouanneau E; Roy P; Trouillas J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3368-3374. PubMed ID: 28651368
[TBL] [Abstract][Full Text] [Related]
11. Primary Cilia as a Tumor Marker in Pituitary Neuroendocrine Tumors.
Martínez-Hernández R; Serrano-Somavilla A; Fernández-Contreras R; Sanchez-Guerrero C; Sánchez de la Blanca N; Sacristán-Gómez P; Sebastian-Valles F; Sampedro-Núñez M; Fraga J; Calatayud M; Vicente A; García-de-Casasola G; Sanz-García A; Araujo-Castro M; Ruz-Caracuel I; Puig-Domingo M; Marazuela M
Mod Pathol; 2024 May; 37(5):100475. PubMed ID: 38508520
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.
Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S
Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566
[TBL] [Abstract][Full Text] [Related]
13. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
14. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
16. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
[TBL] [Abstract][Full Text] [Related]
17. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
[TBL] [Abstract][Full Text] [Related]
18. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.
Iuchi T; Saeki N; Osato K; Yamaura A
Acta Neurochir (Wien); 2000; 142(12):1345-51. PubMed ID: 11214627
[TBL] [Abstract][Full Text] [Related]
19. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
20. Cavernous sinus invasion and tumor proliferative potential of growth hormone-producing pituitary tumors.
Iuchi S; Saeki N; Uchino Y; Higuchi Y; Tatsuno I; Nakamura S; Yasuda T; Yamaura A
Endocr J; 2000 Mar; 47 Suppl():S77-9. PubMed ID: 10890190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
